AbbVie 2013 Annual Report Download - page 137
Download and view the complete annual report
Please find page 137 of the 2013 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127 -
128 -
129 -
130 -
131 -
132 -
133 -
134 -
135 -
136 -
137 -
138 -
139 -
140 -
141 -
142 -
143 -
144 -
145 -
146 -
147 -
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
 |
 |
SECURITIES OWNERSHIP
Securities Ownership of Executive Officers and Directors
The table below reflects the number of shares of AbbVie common stock beneficially owned as of
January 31, 2014, by each director, the chief executive officer, the chief financial officer, and the three
other most highly paid executive officers (the ‘‘named executive officers’’), and by all directors and
executive officers of AbbVie as a group. It also reflects the number of stock equivalent units and
restricted stock units held by non-employee directors under the AbbVie Non-Employee Directors’ Fee
Plan.
Stock Options
Exercisable
Shares within 60 days Stock
Beneficially of January 31, Equivalent
Name Owned(1)(2)(3) 2014 Units
R. Gonzalez ..................................... 284,053 283,743 0
R. Alpern ....................................... 11,094 0 718
R. Austin ....................................... 25,601 0 0
W. Burnside ..................................... 2,535 0 0
E. Liddy ........................................ 7,656 0 0
E. Rapp ........................................ 5,035 0 3,011
R. Roberts ...................................... 22,535 0 0
G. Tilton ....................................... 22,091 0 3,148
F. Waddell ...................................... 4,535 0 0
L. Schumacher ................................... 247,296 296,738 0
W. Chase ....................................... 140,620 137,472 0
C. Alban ....................................... 216,521 116,477 0
T. Richmond ..................................... 90,165 29,014 0
All directors and executive officers as a group(4) ........... 1,147,419 907,617 6,877
(1) The table includes shares held in the executive officers’ accounts in the AbbVie Savings Plan as
follows: all executive officers as a group, 16,937. Each executive officer has shared voting power
and sole investment power with respect to the shares held in his or her account.
(2) The table includes 14,833 restricted stock units held by the executive officers as a group. The
executive officers do not have sole voting and investment power until the restrictions lapse. The
table also includes restricted stock units held by the non-employee directors. The directors’ units
are payable in stock as described in footnote (2) to the Director Compensation table.
(3) The table includes shared voting and/or investment power over shares as follows: G. Tilton, 350;
W. Chase, 501; C. Alban, 40,442; and all directors and executive officers as a group, 42,485.
(4) The directors and executive officers as a group together own less than one percent of the
outstanding shares of AbbVie.
14